北京美科美生物公司代理4saliva

iSWAB™ – Microbiome Kit
BioServUK – MagBead Viral RNA Lysis Buffer
Duplex Real-Time PCR Kit for Rapid Detection of 2019-nCoV ORF1ab / N gene
Real-Time PCR Kit for Rapid Detection of 2019-nCoV E gene
Multiple Real-Time PCR Kit for Detection of 2019-nCoV
PhoenixDx® Detection System
Pedia•SAL™
Pure•SAL™
RNAPro•SAL™
SimplOFy™
Super•SAL™
Micro•SAL™ for Children
Micro•SAL™ for Animals
DNA•SAL™
VerOFy® & LIAM™
Accu•SAL™
Versi•SAL®
UltraSal-2™
Fem•Collect™
Mini•SAL™ and Midi•SAL™
Molzym Products
BlackHills Diagnostics Products
COVID-19 Assays
ViennaLab
IBL International
Operon S.A.
绿洲诊断公司（Oasis Diagnostics®Corporation）成立于2002年，旨在满足生命科学领域对快速检测、样本采集和分子诊断（DNA、RNA和蛋白质）的无创唾液技术的日益增长的需求。该公司致力于满足对更有效筛查工具的需求，该工具可应用于疾病和医疗疾病的早期检测，利用非侵入性样本，尤其是口腔液体（唾液）。
该公司的一系列收集和（未来）诊断工具涵盖在美国、欧盟和国际专利组合中
认识到早期诊断是全球疾病预防的关键，该公司将其研究工作转向开发基于口腔的快速、定点护理、实验室和分子产品，这符合为全球客户提高医疗质量的企业目标。
Oasis Diagnostics® Corporation was founded in 2002 to address a growing need for non-invasive saliva based technology for rapid testing, sample collection, and molecular diagnostics [DNA, RNA and proteins] in the Life Sciences area. The Company is dedicated to meeting the need for more effective screening tools, which may be applied to the early detection of diseases and medical disorders, utilizing non-invasive test specimens, particularly oral fluids (saliva).
The Company’s range of collection and [future] diagnostic tools are covered by a portfolio of issued US, EU and International patents
Recognizing that early diagnosis is the key to disease prevention on a global basis, the Company directs its research efforts towards the development of oral based rapid, point-of-care, laboratory-based and molecular products, which fit into a Corporate objective of improving the quality of healthcare for our global customers.